• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Former FDA Director Joins Greenleaf Health

    Alexander D’Amico Named Chief Financial Officer at CytoSorbents

    Moon Surgical Completes First U.S. Cases with Maestro System

    Senseonics Finishes 365-Day CGM Study Cohort

    Surface Solutions Group to Showcase GlideMed Coating at MD&M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Back to School for Medical Device Cybersecurity Training

    Driving Clinical Trial Excellence to Help Study Teams Run a Faster Relay Race

    Medtech’s Supply Chain: From Disruption to Opportunity

    Are Medtech’s Mega-Deals Gone For Good?

    Will a Skilling Gap Hinder Organizational Readiness for Medtech’s New Age of AI?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    LEMO USA Inc.

    Arthur G. Russell Co. Inc., The

    Medbio LLC

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Wearables Are Changing the Way We Collect Real-World Data in Clinical Trials

    Could Medtech Ever Stop a Hospital Killer in Their Tracks?

    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    LEMO USA Inc.

    Arthur G. Russell Co. Inc., The

    Medbio LLC

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Used Medical Equipment: A Source of Anxiety for the FDA

    ...

    Used Medical Equipment: A Source of Anxiety for the FDA
    James A. Dunning, CEO, QPC Services11.08.16
    An eBay search for medical devices (listed under the medical equipment category) is likely to yield various types of used medical equipment—magnetic resonance imaging machines, for example, negative pressure wound therapy systems, X-ray machines, infusion pumps, and heart-lung machines, among others.

    For many years, the U.S. Food and Drug Administration (FDA) has sought to clarify its regulatory requirements and expectations under 21 CFR Part 820 to entities servicing, refurbishing, rebuilding, reconditioning, remarketing, and remanufacturing medical devices. In addition, FDA medical device regulations mandate that device manufacturers establish and maintain instructions and procedures for servicing. However, in the Dec. 4, 1998 Federal Register (63 FR 67076), medical devices were excluded from compliance with the 1997 Quality System Regulation.

    Since then, the FDA has established some regulatory requirements for refurbished/serviced medical equipment. The Electronic Product Radiation Control requirements of the Food, Drug and Cosmetic Act (Pub. L. 90-602, amended by Pub. L. 103-80), include provisions specific to manufacturers and assemblers of certified X-ray components. Under 21 CFR Part 1020.30(c), manufacturers of diagnostic X-ray systems are responsible for providing assembly instructions adequate to ensure compliance of their components with the applicable performance standards when installed properly. Furthermore, under 21 CFR Part 1020.30(d), assemblers are required to assemble, install, adjust, and test the certified components according to the instructions of their respective manufacturers. The FDA has previously issued guidance on these topics, including an Assembler’s Guide to Diagnostic X-ray Equipment and Information Disclosure by Manufacturers to Assemblers for Diagnostic X-ray Systems. Under the EPRC provision in 21 CFR 1040.10(h)(1)(i), manufacturers of laser products must provide instructions for assembly, operation, and maintenance, including warnings and precautions on how to avoid exposure, and maintenance schedules to ensure the product complies with standard requirements.

    Yet the current regulations are unsatisfactory for many medtech executives and policymakers. The FDA, for example, is concerned that third-party entities who refurbish, recondition, rebuild, remarket, remanufacture, service, and repair medical devices could use unqualified personnel to perform service, maintenance, refurbishment, and device alterations on their equipment. The agency also worries about adequate documentation of the work and potential public health issues arising from these activities. Some specific concerns are:
    1. Improper device operation
    2. Faulty device safety systems
    3. Ineffective recalls 
    Earlier this year, the FDA issued a docket to request feedback from the industry, particularly those involved in the activities previously noted or who utilize refurbished, reconditioned, rebuilt, remarketed, remanufactured, or third-party serviced and repaired medical devices. The docket, FDA claims, was triggered by concerns about the quality, safety, and continued effectiveness of used medical devices handled by original equipment manufacturers (OEM) and third parties, including healthcare establishments. The docket asks for input on the following proposed definitions:
    1. Recondition: Restores and/or refurbishes a medical device to the OEM’s original specifications. Under limited circumstances, the medical device may be restored and/or refurbished to current specifications.
    2. Service: Maintenance or repair of a finished device after distribution for purposes of returning it to the safety and performance specifications established by the OEM and to meet its original intended use. Servicing cannot change the intended use(s) of the device from its original purpose(s).
    3. Repair: Return the device or component to original specifications, including replacing non-working components or parts outside of routine or periodic upkeep for the  current owner of the device.
    4. Refurbish: Restore device to a condition of safety and effectiveness that is comparable to when new. This includes reconditioning, repair, installation of certain software/hardware updates that do not change the intended use of the original device, and replacement of worn parts.
    5. Remanufacture: Process, condition, renovate, repackage, restore, or any other act done to a finished device that significantly changes the finished device’s performance, safety specifications, or intended use.
    6. Remarket: The act of facilitating the transfer of a previously owned device from one party to another by sale, donation, gift, or lease.
    Besides requesting comments on these definitions, the FDA wants feedback about their associated benefits and risks. Feedback is welcomed on the following questions: 
    1. Who are the different stakeholders involved with the medical device activities listed previously? What are their respective roles?
    2. What evidence exists regarding actual problems with the safety and/or performance of devices that result from these activities? Specific examples should be submitted.
    3. What are the potential risks (patients/users) and failure modes (devices) introduced as a result of performing the previously defined activities on medical devices? Please speak to issues common to all devices as well as specific risks with specific devices.
    4. These activities are performed by OEMs and various third-party entities, including hospitals and humanitarian organizations. Are the risks different depending on who performs the previously mentioned activities?
    5. We are interested in knowing if these activities are more difficult or riskier to perform on certain devices versus others. Please cite specific examples in your response, along with an explanation of the source of this particular complexity.
    6. What information do third-party entities need in order to perform these activities in a way that results in safe and effective operation of the medical device? Provide specific examples.
    7. What additional challenges do stakeholders encounter with devices that result from these activities?
    The following three excerpts were extracted from the more than 175 comments submitted thus far to the FDA. The full list of comments is available at bit.ly/mpo161250.

    Comment Excerpt (1) 
    In the industry of third-party ultrasound equipment repair, a wide range of interpretations and definitions exist about how to restore and/or refurbish ultrasound medical devices back to a quality healthcare facilities expect. Third parties attempt to remanufacture critical parts of the medical device, but to a specification they believe to be standard operational conditions. For example, a critical part may be remanufactured to a specification that they feel matches performance needs; however, the holistic characteristics such as ergonomics, temperature control, HIPOT, leakage, and form factor are often ignored. These issues are the same for third-party companies attempting to make any changes to medical devices to a newer specification.

    Using non-OEM measuring devices to analyze transducers is also a common practice with some repair facilities. These devices are ultrasound machine simulators that provide snapshots and do not properly capture intermittent issues that require more intensive testing. This method is fine when used in conjunction with the intended testing machines the devices are used on, but cannot be used solely as a substitute. There are certain features, such as thermal monitoring and electromechanical control mechanisms, that can only be properly tested for functionality or faults on a native ultrasound machine.

    The customer is often unaware of the low-quality remanufactured components inside ultrasound transducers because they are encased inside the outer body shell. This poses an ethical issue of disclosing what the customer is ordering relative to the OEM part number requested. If the transducer does not have OEM parts and materials, it should be disclosed at the time of sale to the hospital. This disclosure provides the opportunity to avoid unnecessary safety risks.

    Comment Excerpt (2)
    In over 25 years of laser service, we have not had any safety or performance issues reported as a result of our technicians servicing equipment. I do recall a recent occasion in which a customer called us to service a laser that was one year old, just out of warranty, in which they were having problems with. The OEM had serviced the unit and found no problem. Our technician found a factory defect in which metal shavings were left in the articulated arm, causing focusing issues for the customer. The OEM technician was not able to find the problem, but our technician did.

    We require our technicians have formal electronic or biomedical training. There are multiple OEMs that subcontract us to perform service on their behalf.

    Comment Excerpt (3)
    If there is a lack of uniform performance, its genesis may be the failure of some original equipment manufacturers to readily supply AIAT [Assemble-Install-Adjust-Test] information. IAMERS [International Association of Medical Equipment Remarketers and Servicers] has continually expressed concerns that some original equipment manufacturers have consistently failed to fulfill disclosure requirements. Under the relevant regulations, including those in Title 21 of the Code of Federal Regulation, Parts 820.170 and 1020.30, OEMS are required to provide certain information to third-party servicers and installers. As the FDA has noted, “...it is the FDA’s responsibility to hold OEMs accountable for providing required information to third parties where appropriate for ensuring the safe and effective operation of medical devices.”

    Conclusion
    In researching this column and reading many of the comments submitted to the FDA, several key issues became obvious:
    • OEMs and third-party service organizations have a clear point of view about servicing and repairing refurbished or reprocessed devices.
    • The FDA‘s concerns about device service and repair by OEMs and third-party service organizations have not changed in 20 years.
    • The patient must be the main concern of any organization involved in servicing medical equipment.
    Third-party service organizations provide a critical service, particularly in cases when OEMs announce the end of life for their medical equipment. Although many users will upgrade—which is almost always an option—many may not, especially users who cannot afford to update to the most current technology. Thus, the current level of regulatory oversight is concerning to many organizations.

    I sincerely hope the FDA issues additional regulatory requirements for third-party service organizations and OEMs that service their own equipment. An update is long overdue. 


    James A. “Jim” Dunning’s consulting career began in 2001. He has provided quality and regulatory consulting services for various companies ranging from Fortune 500 medical device firms to startups. Dunning’s passion, however, lies with startups and small companies, especially those in regulatory distress. He has amassed significant experience in preparing 510(k) applications, developing complete Quality Management Systems, providing Quality System Training, and advising on quality, business, and leadership issues. Dunning is a senior member of the American Society for Quality (ASQ) and a member of the Regulatory Affairs Professional Society (RAPS). He can be reached at jdunning@qpcservices.com 
    Related Searches
    • lifepak 1000 defibrillator
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    CE Mark Granted to Predictive Software for Kidney Allograft Survival CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    Presidio Medical Names Michael Onuscheck as CEO Presidio Medical Names Michael Onuscheck as CEO
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    Molli Surgical Molli Surgical's Breast Tumor Marker
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    RapidPulse Closes $15 Million Series A Financing RapidPulse Closes $15 Million Series A Financing

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • BMP Medical - Delivering Custom Plastics Manufactured Solutions

      BMP Medical - Delivering Custom Plastics Manufactured Solutions

      Medical Contract Manufacturing, Design, Assembly & Packaging

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21


    • Tubing & Extrusion
      Accu-Tube Appoints Matthew Haddle as CEO

      Accu-Tube Appoints Matthew Haddle as CEO

      Haddle has a track record of leading organizations through strategic expansions across the medical device, aerospace, and industrial sectors.
      Accu-Tube 09.22.21

    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    Loading, Please Wait..

    Trending
    • Cardiosense Begins SEISMIC-HF I Heart Failure Trial
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • Exo Introduces The Exo Iris To Market
    • A New Approach To Post-Market Surveillance
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    Breaking News
    • New Data Shows Advantages of Rapid Medical’s COMANECI Embolization Assist Device
    • Former FDA Director Joins Greenleaf Health
    • Alexander D’Amico Named Chief Financial Officer at CytoSorbents
    • Moon Surgical Completes First U.S. Cases with Maestro System
    • Senseonics Finishes 365-Day CGM Study Cohort
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    Alabama Students Gain Real-World Experience with Internships at BASF
    AkzoNobel Names Sweet Embrace as Interpon Color of the Year 2024
    PPG’s New Paint for a New Start Transforms 27 Schools Worldwide with Colorful Makeovers
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Alexander D’Amico Named Chief Financial Officer at CytoSorbents
    Moon Surgical Completes First U.S. Cases with Maestro System
    Senseonics Finishes 365-Day CGM Study Cohort
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Ginkgo Bioworks, Pfizer Enter Multi-Target RNA Discovery Alliance
    WuXi Vaccines Launches Vaccines CDMO Site in China
    MilliporeSigma Launches Integrated mRNA Services
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top 10 Most Popular Fashion Designer Makeup Brands—According to Landys Chemist
    Jennifer Coolidge Collaborates with e.l.f. Cosmetics for 'Dirty Pillows' Lip Collection
    Victoria Beckham Beauty Introduces First Fragrance Collection
    Happi

    Latest Breaking News From Happi

    Bio-Oil Launches 'Labor of Love' Campaign
    Wharton To Honor Leonard A. Lauder with Retail Excellence Award
    Extracts-Unlimited Attains Organic Certification
    Ink World

    Latest Breaking News From Ink World

    Sapphire Ink – SB Eco Series Receives Oeko-Tex Eco Passport ZDHC Level 3 Certification
    Flint Group Digital with Xeikon Present at FEFCO Technical Seminar
    R.E. Carroll Inc. Packs, Donates 400 Backpacks to Students
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Bobst to 'unwrap the future of flexible packaging' at open house
    IDENTCO brings new automated wire marking system to Mexico
    Maan Engineering chooses Vetaphone for linerless labels
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ana Fraisse Joins The American Cleaning Institute
    Weekly Recap: Soft N' Dry Seeks to Expand Private Label Roll Out, Albis Completes Work on Line
    Lenzing Earns EU Ecolabel at Indonesian Plant
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ONWARD Completes First-in-Human for ARC-IM to Restore Upper Extremity Function
    Michael S. Aronow Installed as AOFAS President
    Abyrx's MONTAGE Settable Bone Putty Cleared for Cardiothoracic Surgery
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    PPG and Flō-Optics Enter Exclusive Supplier Agreement
    SEMI North America Advisory Board Adds New Members
    Nhat Tin Logistics Enhances Operations with Zebra Technologies

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login